Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Intas Pharmaceuticals announces European Commission approval and completion of its purchase of an Out-licensing basket of products from TEVA

Intas Pharmaceuticals
Posted on: 02 Mar 18

Intas Pharmaceuticals is pleased to announce EC approval has been granted for its purchase of rights to a portfolio of 12 products from TEVA.  

This transaction forms part of the European Commission’s (EC) anti-trust divestiture requirements arising from TEVA’s acquisition of Allergan’s generics business, more commonly referred to as the ‘Out-licensing Basket’ and is one of the “baskets” acquired by Intas Group from TEVA. Completion of this transaction follows completion of Accord Healthcare’s acquisition of the Actavis UK & IE business from TEVA in January 2017.

The deal includes the rights to 12 products, together with the associated supply contracts to a platform of more than 25 different customers in the European Union. This business was formerly led by Teva’s out-licensing unit Medis.  

The products included in the basket are Acetylsalicylic acid, Alendronic acid, Ipatropium+Salbutamol, Lisinopril, Oxaliplatin lyophilized and liquid, Risedronic acid, Triamterene+HCTZ, Nifedipine, Benazepril, Benazepril+HCTZ and Quinapril+HCTZ.

Marc Comas, EVP-Global Licensing and Third Party Sales for Intas said: “Our vision is to become one of the most active players in the Out-licensing & B2B of pharmaceuticals in Europe. With this acquisition, we add a basket of new products to our already broad portfolio and reinforce our strong positioning in the out-licensing business. On top of that, we will also enlarge our platform of partnerships throughout the European market.”

Editor's Details

Hayley Jayawardene
Hayley Jayawardene Limited
hayley@jayawardeneltd.com

Last updated on: 02/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.